Anavex Life Sciences Corp (AVXL)

[nidan7500]

Bear nailed it:

Anavex has basically put the scientific/investing world on notice that our compounds, and 2-73 in particular, SEEM to be illustrating (through results and publications) that they may very well be efficacious for AD, Epilepsy, PDD, RSD, MS?, FTD, autism, among other benefits/indications.

AND that they can illustrate how/why, correlated to established biomarkers (something the FDA has encouraged, on paper at least, for new PM initiatives).

And that we aren’t interested in or pursuing BP’s failed symptoms-based approach, but rather we are targeting/solving the root causes of these diseases.

This is exactly what AVXL has done. They present an outline/model on how to apply FDA Precision Medicine requirements when developing a product and testing process-protocol.

In fact I heard Dr.M. during yesterday's conference say..., "WE KNOW EXACTLY WHAT THE A2-73 molecule works as it does and WHY...". He sounded like a physics major not s soft science guy at all. It was just great to hear that kind of fact based reasoning. No hand wringing (soft speak). It was an in your face hard science moment. Which he recovered from when he realized where he was.

Just the best...WE REALLY GOT THIS.